My SciELO
Services on Demand
Article
Indicators
- Cited by SciELO
Related links
- Similars in SciELO
Share
Vaccimonitor
On-line version ISSN 1025-0298
Abstract
VAZQUEZ-ROMERO, Javier Eduardo and ROMEU-ALVAREZ, Belkis. Anti-COVID-19 vaccines: a look from the regulatory perspective. Vaccimonitor [online]. 2022, vol.31, n.2, pp. 90-99. Epub Aug 01, 2022. ISSN 1025-0298.
The development of anti-COVID-19 vaccines has been one of the main priorities of the global scientific community. To date, multiple vaccines have been approved for use by numerous countries, and the World Health Organization has already included some of these in its emergency use listing program. This paper offers information on these aspects and analyzes the colossal challenge that facing the growing development of vaccines against COVID-19 has represented for the regulatory sector, ensuring their quality, safety and efficacy. Similarly, new approaches in the development of clinical trials are addressed, or modifications in existing regulatory procedures that have been carefully adapted by regulatory agencies, without losing their scrutiny capacity and the integrity of the scientific-regulatory evaluation.
Keywords : COVID-19; vaccines; medical device legislation; clinical trial.